醋酸环丙孕酮（新西兰 Siterone）说明书 ↩ ↩2 ↩3
醋酸环丙孕酮（台湾 Androcur）说明书 ↩ ↩2 ↩3
Coleman E, Radix A E, Bouman W P, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 [J]. International Journal of Transgender Health, 2022, 23(Suppl 1): S1–S259. DOI: 10.1080/26895269.2022.2100644 ——中文译本 ↩ ↩2 ↩3
Kumari G L, Das R P, Madoiya K K, et al. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human [J]. Fertility and sterility, 1977, 28(11): 1168–1174. DOI: 10.1016/S0015-0282(16)42912-2 ↩
Wikipedia. Chlormadinone acetate [EB/OL]. (2023-11-25)[2024-05-01]. https://en.wikipedia.org/wiki/Chlormadinone_acetate ↩ ↩2
Aly. Low Doses of Cyproterone Acetate Are Maximally Effective for Testosterone Suppression in Transfeminine People [EB/OL]. Transfeminine Science, 2019. 译文：《低剂量的醋酸环丙孕酮足以最大限度地抑制女性倾向跨性别者的睾酮水平》 ↩ ↩2 ↩3 ↩4
Warzywoda S, Fowler J A, Bisshop F, et al. How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones [EB/OL]. International Journal of Transgender Health, (2024-02-20). DOI: 10.1080/26895269.2024.2317395 ↩
Aly. Recent Developments on Cyproterone Acetate and Meningioma Risk Out of France and Implications for Transfeminine People [EB/OL]. Transfeminine Science, 2020. 译文：《法国关于醋酸环丙孕酮和脑膜瘤风险的研究的最新进展以及对女性倾向跨性别者的影响》 ↩
Ramsay I D, Rushton D H. Reduced serum vitamin B12 levels during oral cyproterone-acetate and ethinyl-oestradiol therapy in women with diffuse androgen-dependent alopecia [J]. Clinical and Experimental Dermatology, 1990, 15(4): 277–281. DOI: 10.1111/j.1365-2230.1990.tb02089.x ↩
Sadock B J, Ahmad S, Sadock V A. Kaplan and Sadock's Pocket Handbook of Clinical Psychiatry [M]. 6th ed. Philadelphia, US: Wolters Kluwer, 2018: 92. ↩
Stahnke N, Ilicki A, Willig R P. Effect of Cyproterone Acetate (CA) on Growth and Endocrine Function in Precocious Puberty [J]. Acta Paediatrica, 1979, 68(S277): 32–40. DOI: 10.1111/j.1651-2227.1979.tb06189.x ↩
Yuk J-S. Relationship between menopausal hormone therapy and breast cancer: A nationwide population-based cohort study [EB/OL]. International Journal of Gynecology & Obstetrics, (2024-03-12). DOI: 10.1002/ijgo.15461 ↩
Seaman H E, de Vries C S, Farmer R D T. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case–control study [J]. Human Reproduction, 2003, 18(3): 522–526. DOI: 10.1093/humrep/deg120 ↩
Seaman H E, Langley S E M, Farmer R D T, et al. Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database [J]. BJU International, 2007, 99(6): 1398–1403. DOI: 10.1111/j.1464-410X.2007.06859.x ↩
Aly. Considerations in Understanding the Possible Role and Influence of Progestogens in Terms of Breast Development [EB/OL]. Transfeminine Science, 2020. 译文：《关于孕激素在乳房发育过程中有何潜在作用及影响的随笔》 ↩